Showing results (231-240 of 255) with videos related to
Sort By:
Pageof 26
The New England Journal of Medicine|September 27, 1984
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failureJ N Cohn, T B Levine, M T Olivari, et al.Radiology|November 1, 1977
Evaluation of early myocardial ischemia with thallium-201 in the pigJ S Schwartz, R A Ponto, L A Forstrom, et al.Journal of Clinical Pharmacology|April 29, 1998
The importance of arterial compliance in cardiovascular drug therapyS P Glasser, D K Arnett, G E McVeigh, et al.The New England Journal of Medicine|August 1, 1991
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failureJ N Cohn, G Johnson, S Ziesche, et al.The American Journal of Cardiology|August 1, 1987
Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failureG L Pierpont, G S Francis, E G DeMaster, et al.American Heart Journal|September 1, 1982
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placeboJ A Franciosa, K T Weber, T B Levine, et al.Age and Ageing|August 18, 2001
Relationship between periventricular or deep white matter lesions and arterial elasticity indices in very old peopleD A Duprez, M L De Buyzere, N Van den Noortgate, et al.Journal of Molecular and Cellular Cardiology|May 18, 1999
Localization of changes in beta-actin expression in remodeled canine myocardiumB Tian, W C Carlyle, W G Weigold, et al.Circulation|September 15, 1996
Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2'-O-methyladenosine in patients with left ventricular dysfunctionB D Bertolet, I S Anand, R J Bryg, et al.Circulation|December 1, 1994
Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dogK M McDonald, M Garr, P F Carlyle, et al.Pageof 26